EU Parliament Urges Revision of MDR and IVDR
The European Parliament has published the adopted text of a resolution entitled ‘Urgent need to revise the medical…
Stay informed with real-time regulatory news and expert insights, and keep the conversation going by connecting with us on social media.
Showing 172–180 of 635
The European Parliament has published the adopted text of a resolution entitled ‘Urgent need to revise the medical…
On 16 October, an amendment to Australian legislation was published that expands the conditions for medical devices already marketed in…
The FDA issued draft guidance on September 19, 2024, concerning its recommendations related to chemical analysis for biocompatibility assessment of…
Currently the FDA recognizes 100’s of consensus standards from reputable organizations such as ISO, ANSI, AAMI, IEC, ASTM, etc. These…
The final rule related to medical devices and LDTs (Laboratory Developed Tests) was finalized in April 2024 by the FDA.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has introduced the first significant update to…
User guides have been updated to include the transition eligibility content. While custom made devices are now exempt from requirement…
The MDCG 2021-25 (Rev1.0) has been updated, reflecting the latest developments in the MDCG MDR Transition. The guidance now takes…
Similar to the role of Economic Operators, it is important to recognize that Regulation (EU) 2017/745 (MDR) includes a…
Showing 172–180 of 635